GlaxoSmithKline, Plc. has indicated that their attempts to obtain approval for their diabetes drug, Avandia, to be used to treat Alzheimer’s disease have been delayed. Concerns about Avandia heart attacks have caused many potential participants in their Alzheimer’s studies to drop out. The drug maker was hoping to gain approval… Read more.

A new study released yesterday raises further concerns about Avandia heart risks, especially among older diabetics. Canadian researchers found that when compared with other treatments for type 2 diabetes, seniors using Avandia face a substantially higher risk of heart attacks, congestive heart failure and death. >>INFORMATION: Avandia Heart Attack Risk 

Avandia has been the subject of a lot of attention recently as a result of studies which found that the type II diabetes drug increases the risk of heart problems.  A new study released this week provides additional information about another Avandia side effect, which could increase the risk of… Read more.

Diabetes associations from the United States and Europe indicated this week that doctors should exercise greater caution when prescribing oral type 2 diabetes drugs like Avandia and Actos.  An increased risk of heart attacks has been associated with Avandia, and both diabetes drugs have been linked to a risk of… Read more.

The FDA and GlaxoSmithKline officially announced earlier this week that an Avandia black box warning will be added to the diabetes drug regarding heart attacks.  However, many do not believe that the warning does enough to inform users about the risk of serious injury or death which could be caused… Read more.

The makers of Avandia, GlaxoSmithKline, PLC, have placed new restrictions in Canada on the use of their popular type II diabetes drug.  The new labeling comes after a Health Canada review of clinical data found an increased risk of heart related problems.  Earlier this year, a report published in the… Read more.

The Wall Street Journal reports today that an internal FDA board narrowly voted earlier this month against an Avandia recall.  The federal drug regulators appear to be preparing a “black box” warning about the risk of heart attacks instead of removing the diabetes drug from the market. >>INFORMATION: Avandia Heart… Read more.

GlaxoSmithKline, PLC was dealt two new blows last week from the Department of Veteran Affairs and the European Medicines Agency, which will ad to their Avandia problems.  The V.A. has indicated that they will be severely limiting the use of Avandia among U.S. veterans and Europe’s drug regulators announced that… Read more.

A new study confirms that the diabetes drugs Actos and Avandia increase the risk of heart failure.  Both drugs previously received a “black box” warning about congestive heart failure in June, and they have been the subject of several studies since a report in published in May found that users… Read more.

According to a new study presented earlier this week, the diabetes drug Actos may be better than Avandia at controlling blood sugar and lipid levels.  Over the past few months, many individuals who have been given Avandia to treat their type 2 diabetes, have been concerned about the safety of… Read more.